1M+
3
60+
700
COVID-19 Research
More than one-fifth of Fred Hutch researchers have active projects related to COVID-19. Across the organization, scientists are tackling all aspects of the disease and the SARs-CoV-2 virus that causes it — including coordinating vaccine development, testing potential therapies, tracking how it spreads, how it affects our bodies and how to safely return to schools and offices.
Our Commitment
Fred Hutch is committed to becoming an anti-racist institution. In this endeavor, we are determined to strengthen and deepen our efforts that affirm the equal rights, value and protection of Black people and other minority communities — in the streets, on our campus and in our science.
This spring, we assessed our progress toward our goals and released an annual report in early June.
Meet Our Researchers
View All Faculty & Labs
Helping in Behavior Change
By combining cutting-edge psychology and technology, Dr. Jonathan Bricker is working to help millions of people adopt healthier habits that reduce their cancer risk. His research program uses a paradigm called Acceptance and Commitment Therapy to help participants overcome urges, such as the urge to smoke. ACT encourages people to notice and accept these feelings, with the understanding that they will disappear on their own.
Toward New Liver Cancer Drugs
Dr. Abir Arfaoui studies a rare liver cancer called fibrolamellar carcinoma. FLC is resistant to most chemotherapies, even drugs that target other forms of liver cancer, and is often fatal in the young patients it affects. The goal of her research is to determine the signaling pathways that drive these tumors’ growth and to develop an effective treatment that brings the hope of cure to those who are diagnosed with FLC.
Upcoming Events
Find More Events >Science Says
Your search for "" did not match any of our events. Please try another event term or combination of terms and filters.
Help Us Eliminate Cancer
Every dollar counts. Please support lifesaving research today.